[Skip to Content]
[Skip to Content Landing]
March 27, 1954


JAMA. 1954;154(13):1094. doi:10.1001/jama.1954.02940470046016

Reports on the use of gamma globulin as a prophylactic agent for paralytic poliomyelitis have been published previously in The Journal.1 All these reports offered promise. None implied that gamma globulin provides the best possible means of preventing paralytic complications following the development of anterior poliomyelitis, but all left the reader with the suggestion that gamma globulin was worthy of trial.

In this issue (page 1086) is a summary of the report of the National Advisory Committee for Evaluation of Gamma Globulin. The study was sponsored by the United States Public Health Service in collaboration with the Association of State and Territorial Health Officers, the American Physical Therapy Association, and the D. T. Watson School of Physiatrics, affiliated with the University of Pittsburgh School of Medicine. Health departments in 41 states and 4 cities actively collaborated in the study. The committee, with the exception of one member, concluded that

First Page Preview View Large
First page PDF preview
First page PDF preview